Frailty in Pancreas Transplantation

Area of Science:

• Gerontology
• Transplant Surgery
• Nephrology

Background:

• Frailty is clinically defined by 5 phenotypic criteria: low grip strength, low energy, slowed walking speed, low physical activity, and unintentional weight loss.
• Patients with diabetes or chronic kidney disease (CKD) have an increased risk of frailty.
• Pancreas transplant candidates, who typically have diabetes and often CKD, are at high risk for frailty.

Purpose of the Study:

• To investigate the impact of frailty on pancreas transplantation outcomes.
• To highlight the high prevalence of frailty phenotypes in pancreas transplant candidates.
• To synthesize existing data on frailty in CKD, diabetes, and solid organ transplant recipients due to limited specific data in pancreas transplantation.

Main Methods:

• Review of operational frailty definition (3 of 5 phenotypic criteria).
• Analysis of frailty prevalence in populations with diabetes, CKD, and solid organ transplants.
• Inclusion of data from CKD, diabetes, and solid organ transplant recipients to infer potential impact on pancreas transplantation.

Main Results:

• Frailty is prevalent in solid organ transplant candidates and recipients, associated with lower transplant rates and higher waitlist mortality.
• Frail patients experience increased risks of prolonged hospitalization, readmission, and delayed graft function post-transplant.
• Phenotypes of frailty, such as sarcopenia and fatigue, are highly prevalent in pancreas transplant candidates.

Conclusions:

• Pancreas transplant candidates and recipients are at significant risk of frailty due to underlying conditions like diabetes and CKD.
• Frailty is expected to negatively impact pancreas transplantation outcomes, similar to or worse than other solid organ transplants.
• Further research is needed to specifically address frailty in pancreas transplant recipients to optimize patient care and outcomes.